Get access

Bypassing T cells using a B cell mimotope allergy vaccine

Authors


  • This editorial discusses the findings of the paper in this issue by Wallman et al. [19] pp. 650-658.

Correspondence:
G. Gafvelin, Karolinska Institutet, Department of Medicine, Clinical Immunology and Allergy Unit, Karolinska University Hospital L2:04, 171 76 Stockholm, Sweden. E-mail: guro.gafvelin@ki.se

Abstract

Cite this as: G. Gafvelin, Clinical & Experimental Allergy, 2010 (40) 528–530.

Ancillary